Dr. Fabio Cury, MD
Claim this profileMcGill University Health Centre-Cedars Cancer Centre
Studies Prostate Cancer
Studies Soft Tissue Sarcoma
6 reported clinical trials
13 drugs studied
Area of expertise
1Prostate Cancer
metastatic
localized
testosterone
2Soft Tissue Sarcoma
Stage IV
Affiliated Hospitals
Clinical Trials Fabio Cury, MD is currently running
SBRT
for Prostate Cancer
It is a phase I study of radical hypofractionation delivering one single fraction of SBRT in patients with low- and favorable intermediate-risk prostate cancer that will undergo placement of the SpaceOAR hydrogel prior to treatment. Our hypothesis is that treatments can be safely delivered in one single fraction using SBRT provided the separation between the prostate and rectum is increased using the hydrogel
Recruiting1 award N/A6 criteria
Hypofractionated Radiation Therapy + Eligard
for Prostate Cancer
Prostate cancer is the second most common cancer among Canadian men of which approximately 20-30% present with high-risk tumour characteristic. Although surgery can be curative in patients evidencing pathological high-risk disease (extracapsular extension, seminal vesicle involvement, positive surgical margins), a large proportion will develop biochemical failure within years from the surgical procedure. The failure rate is even more pronounced in those patients that present with high prostate specific antigen (PSA) levels, pT3 disease, positive margins and Gleason score ≥8 with an estimated 75% failure rate at 10 years. Post-operative radiotherapy (RT) has been shown in three randomized trials to significantly decrease the biochemical failure rate and in one of the trials a survival benefit was also seen with the addition of post-operative RT and is considered by many investigators standard therapy in patients with pathological high-risks factors even in absence of biochemical failure.
Recruiting2 awards Phase 210 criteria
More about Fabio Cury, MD
Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Fabio Cury, MD has experience with
- SBRT
- Hypofractionation
- Eligard
- Postop Hypofractionated Radiation Therapy
- Enzalutamide
- Goserelin Acetate
Breakdown of trials Fabio Cury, MD has run
Prostate Cancer
Soft Tissue Sarcoma
Metabolic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fabio Cury, MD specialize in?
Fabio Cury, MD focuses on Prostate Cancer and Soft Tissue Sarcoma. In particular, much of their work with Prostate Cancer has involved metastatic patients, or patients who are localized.
Is Fabio Cury, MD currently recruiting for clinical trials?
Yes, Fabio Cury, MD is currently recruiting for 2 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Fabio Cury, MD has studied deeply?
Yes, Fabio Cury, MD has studied treatments such as SBRT, Hypofractionation, Eligard.
What is the best way to schedule an appointment with Fabio Cury, MD?
Apply for one of the trials that Fabio Cury, MD is conducting.
What is the office address of Fabio Cury, MD?
The office of Fabio Cury, MD is located at: McGill University Health Centre-Cedars Cancer Centre, Montréal, Quebec H4A 3J1 Canada. This is the address for their practice at the McGill University Health Centre-Cedars Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.